Skip to main content
Caplight Logo









SIME Diagnostics

SIME Diagnostics

Private
LondonHealthcare & Life Scienceshttps://simedx.com/

Last Round

Grant

Jun 17, 2025

Est. Valuation

$10.67M

Total Funding Raised

$3.94M

Company Overview

SIME Diagnostics is a medical technology company that develops AI-powered point-of-care diagnostic platforms for acute and intensive care settings.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Biotech Equipment, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription, Usage-Based SaaS

AI Layer

Application

Keywords

point-of-care diagnosticsmedical AIclinical AI platformneonatal intensive careNICUrespiratory disease predictionrazor-and-blade modeldiagnostic hardwarereagent-free testingmedtechAI diagnosticsspectroscopyICUusage-based SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SIME Diagnostics Comparables

Compare SIME Diagnostics with similar companies based on industry and business-model similarity.

SIME Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nostics
76%
Etiometry
73%
NeoPrediX AG
69%

SIME Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 17, 2025
SeedJun 10, 2024
SeedMay 12, 2020
GrantJan 11, 2018
AcceleratorMay 30, 2016

SIME Diagnostics Investors

Notable investors and investment history

SIME Diagnostics investors
InvestorRounds
Consilience VenturesSeed
Oxford TechnologySeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 8, 2026

    Monthly visitors grew 68% MoM.

  • Jan 1, 2026

    Monthly visitors grew 48% MoM.

SIME Diagnostics Filings

Explore SEC and related filing metadata, where available.

SIME Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SIME Diagnostics's valuation, stock price, and market status.

Is SIME Diagnostics a public or private company?

SIME Diagnostics is a private company.

What is the current stock price of SIME Diagnostics?

SIME Diagnostics is a private company with no public stock price. No recent secondary market data is available.

How much is SIME Diagnostics worth (valuation)?

SIME Diagnostics's valuation is estimated at $10.7M based on funding round data.

Can I buy SIME Diagnostics stock?

SIME Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SIME Diagnostics's last funding round?

SIME Diagnostics's most recent funding round was Grant on June 10, 2024.

Who are the main investors in SIME Diagnostics?

Key investors in SIME Diagnostics include Consilience Ventures, Oxford Technology.

Will SIME Diagnostics IPO soon?

No public IPO plans have been announced for SIME Diagnostics.

How can I track SIME Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SIME Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range33
Year Founded2014
Last FundingJun 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?